Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Guerbet Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (66)
Cancellation by sponsor (23)
Section 14, TGO91 consent (3)
Prescription medicine registration (2)
Prescription medicine evaluation (1)

Date

2024 (1)
2023 (3)
2022 (2)
2021 (7)
2020 (8)
2019 (5)
2018 (9)
2017 (9)
2016 (8)
2015 (1)
2014 (1)
2013 (1)
2010 (3)
2004 (2)
2003 (4)
2000 (5)
1999 (1)
1997 (2)
1995 (2)
1994 (13)
1993 (4)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

95 result(s) found, displaying 61 to 70

Guerbet Australia Pty Ltd - Syringe, angiography (96947)

16 September 2003

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guerbet Australia Pty Ltd - Syringe, angiography.
Guerbet Australia Pty Ltd Tubing, radiographic procedure (96945)

16 September 2003

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guerbet Australia Pty Ltd Tubing, radiographic procedure.
Guerbet Australia Pty Ltd Contrast - MRI contrast medium injection system, line-powered, stationary (93969)

11 April 2003

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guerbet Australia Pty Ltd Contrast - MRI contrast medium injection system, line-powered, stationary.
Guerbet Australia Pty Ltd - Angiography contrast medium injection system, line-powered, stationary (93438)

10 March 2003

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guerbet Australia Pty Ltd - Angiography contrast medium injection system, line-powered, stationary.
DOTAREM gadoteric acid 279.32mg/mL injection 10mL vial (76925)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 10mL vial.
DOTAREM gadoteric acid 279.32mg/mL injection 20mL vial (76923)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 20mL vial.
DOTAREM gadoteric acid 279.32mg/mL injection 15mL vial (76924)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 15mL vial.
DOTAREM gadoteric acid 279.32mg/mL injection 5mL vial (76926)

11 December 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DOTAREM gadoteric acid 279.32mg/mL injection 5mL vial.
OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe (73580)

6 April 2000

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 320 ULTRAJECT ioversol 50.8g/75mL injection syringe.
OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection syringe (70059)

16 July 1999

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection syringe.

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.